Homer Sun is the Chief Investment Officer of Morgan Stanley Private Equity Asia and leads the fund's China investments. Mr. Sun is also a Managing Director of Morgan Stanley and a member of the China Management Committee which is comprised of Morgan Stanley's most senior business leaders within China. He has served as a director on the boards of Tianhe Chemicals, Sihuan Pharmaceutical, China Shanshui Cement, Nature Flooring, China XD Plastics and Yongye International. Mr. Sun joined Morgan Stanley in 2000 prior to which he was a corporate lawyer with Simpson Thacher & Bartlett in New York and Hong Kong, specializing in mergers and acquisitions. Mr. Sun received a B.S.E. in Chemical Engineering, magna cum laude, from the University of Michigan and a J.D., cum laude, from the University of Michigan Law School.